Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
on the disease mechanisms underlying inherited retinal degeneration and hearing loss, the cell biology of photoreceptors and hair cells, and potential treatments. We utilize mouse models and various approaches in
-
The Klco lab is looking for a post-doctoral fellow interested in using mouse and human models to understand pediatric AML and MDS. We are part of the Department of Pathology and the Center
-
Registry (SCNIR), enabling clinically driven translational research. We employ state-of-the-art experimental models to study the pathomechanism of severe congenital neutropenia and Shwachman-Diamond Syndrome
-
available single-cell sequencing data generated from patient samples and mouse models, we will enhance and apply machine-learning based algorithms to deconvolute bulk tumor RNA-seq samples to distinct immune
-
studies by cryo-electron microscopy (cryo-EM) and/or X-ray crystallography. Perform data processing and model building (e.g., Relion , CryoSPARC , Coot, PyMOL ). Option 2 : Cell Biology Design and execute
-
in live or fixed organisms, cells or tissues - Experience with data analysis in Python, R or similar - Experience working with animal models AND - Experience with mass spectrometry, including sample
-
experimental approaches of the laboratory include molecular-, cellular-, and immunological-based techniques along with animal models of pathogenesis and treatment. Studies are carried out in biosafety level (BSL
-
(TBI). The research will use in vitro and in vivo mouse models. Qualifications: 1). Recent PhD or equivalent degree in neuroscience, molecular biology, physiology, or cerebral vascular biology. 2
-
Postdoctoral Research Associate - Basic and Translational Research Training in Pediatric Classical H
classical hematology, with special emphasis on genomics, gene regulation, and cutting-edge experimental model systems and approaches to mechanistic cell and molecular biology. Trainees will greatly benefit
-
basis of these tumors, which now requires systematic efforts to translate the wealth of genomic discoveries into new experimental models and therapeutic advances. Postdoctoral fellows participating in